Ishigaki, Yasushi

Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017

Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis

Lipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular Prevention

Cited by 813

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Ueki, K., Sasako, T., Okazaki, Y., Kato, M., Okahata, S., Katsuyama, H., Haraguchi, M., Morita, A., Ohashi, K., Hara, K., et al. (2017) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 313

Vagus-macrophage-hepatocyte link promotes post-injury liver regeneration and whole-body survival through hepatic FoxM1 activation

Izumi, T., Imai, J., Yamamoto, J., Kawana, Y., Endo, A., Sugawara, H., Kohata, M., Asai, Y., Takahashi, K., Kodama, S., et al. (2018) · Nature Communications

Liver physiology and pathologyTissue Engineering and Regenerative Medicine

Cited by 109

Chronic mild stress alters circadian expressions of molecular clock genes in the liver

Takahashi, K., Yamada, T., Tsukita, S., Kaneko, K., Shirai, Y., Munakata, Y., Ishigaki, Y., Imai, J., Uno, K., Hasegawa, Y., et al. (2013) · American Journal of Physiology-Endocrinology and Metabolism

Circadian rhythm and melatoninStress Responses and Cortisol

Cited by 63

Virus-mediated Transduction of Apolipoprotein E (ApoE)-Sendai Develops Lipoprotein Glomerulopathy in ApoE-deficient Mice

Ishigaki, Y., Oikawa, S., Suzuki, T., Usui, S., Magoori, K., Kim, D.-H., Suzuki, H., Sasaki, J., Sasano, H., Okazaki, M., et al. (2000) · Journal of Biological Chemistry

Lipid metabolism and disordersRenal Diseases and Glomerulopathies

Cited by 58

Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy

Saito, T., Ishigaki, Y., Oikawa, S., & Yamamoto, T. T. (2002) · Trends in Cardiovascular Medicine

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 25

Clinical inertia in patients with type 2 diabetes treated with oral antidiabetic drugs: Results from a Japanese cohort study (JDDM53)

Maegawa, H., Ishigaki, Y., Langer, J., Saotome‐Nakamura, A., Andersen, M., & the Japan Diabetes Clinical Data Management (JDDM) Study Group (2021) · Journal of Diabetes Investigation

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 18

Role of apolipoprotein E variants in lipoprotein glomerulopathy and other renal lipidoses

Saito, T., Ishigaki, Y., Oikawa, S., & Yamamoto, T. T. (2001) · Clinical and Experimental Nephrology

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 18

Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice

Ishimura, A., Watanabe, M., Nakashima, H., Ito, K., Miyake, K., Mochizuki, S., Ishigaki, Y., & Saito, T. (2009) · Clinical and Experimental Nephrology

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 17

Involvement of oxidative stress in atherosclerosis development in subjects with sarcopenic obesity: Oxidative stress with sarcopenic obesity

Nakano, R., Takebe, N., Ono, M., Hangai, M., Nakagawa, R., Yashiro, S., Murai, T., Nagasawa, K., Takahashi, Y., Satoh, J., et al. (2017) · Obesity Science & Practice

Nutrition and Health in AgingMuscle Physiology and Disorders

Cited by 8